First Bank & Trust Dexcom Inc Transaction History

First Bank & Trust

$510 Million
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	SELL	$75.49 - $124.16 $523,900 - $861,670	-6,940 Reduced 59.23%	4,778 $592,000
Q3 2023 Oct 11, 2023	BUY	$86.06 - $137.93 $50,345 - $80,689	585 Added 5.25%	11,718 $1.09 Million
Q2 2023 Jul 12, 2023	SELL	$112.47 - $130.98 $65,457 - $76,230	-582 Reduced 4.97%	11,133 $1.43 Million
Q1 2023 Apr 25, 2023	BUY	$104.0 - $122.92 $28,496 - $33,680	274 Added 2.39%	11,715 $1.36 Million
Q4 2022 Jan 27, 2023	BUY	$84.98 - $122.67 $20,650 - $29,808	243 Added 2.17%	11,441 $1.3 Million
Q3 2022 Oct 28, 2022	BUY	$76.35 - $94.18 $31,303 - $38,613	410 Added 3.8%	11,198 $902,000
Q2 2022 Jul 22, 2022	BUY	$67.99 - $132.89 $539,636 - $1.05 Million	7,937 Added 278.39%	10,788 $804,000
Q1 2022 Apr 29, 2022	BUY	$94.08 - $130.2 $19,098 - $26,430	203 Added 7.67%	2,851 $1.46 Million
Q4 2021 Feb 01, 2022	SELL	$129.87 - $162.82 $21,038 - $26,376	-162 Reduced 5.77%	2,648 $1.42 Million
Q3 2021 Oct 18, 2021	BUY	$106.71 - $143.18 $2,881 - $3,865	27 Added 0.97%	2,810 $1.54 Million
Q2 2021 Aug 10, 2021	BUY	$80.99 - $107.93 $5,831 - $7,770	72 Added 2.66%	2,783 $1.19 Million
Q1 2021 Apr 14, 2021	BUY	$84.79 - $104.74 $52,230 - $64,519	616 Added 29.4%	2,711 $974,000
Q4 2020 Jan 27, 2021	SELL	$78.0 - $104.5 $53,586 - $71,791	-687 Reduced 24.69%	2,095 $775,000
Q3 2020 Oct 26, 2020	SELL	$95.51 - $112.95 $12,798 - $15,135	-134 Reduced 4.6%	2,782 $1.15 Million
Q2 2020 Aug 05, 2020	SELL	$62.68 - $105.34 $66,628 - $111,976	-1,063 Reduced 26.72%	2,916 $1.18 Million
Q1 2020 Apr 14, 2020	BUY	$47.79 - $75.63 $5,878 - $9,302	123 Added 3.19%	3,979 $1.07 Million
Q4 2019 Jan 31, 2020	SELL	$36.62 - $57.29 $43,138 - $67,487	-1,178 Reduced 23.4%	3,856 $843,000
Q3 2019 Oct 17, 2019	BUY	$35.53 - $43.8 $12,826 - $15,811	361 Added 7.73%	5,034 $751,000
Q2 2019 Jul 26, 2019	SELL	$27.84 - $38.92 $28,118 - $39,309	-1,010 Reduced 17.77%	4,673 $700,000
Q1 2019 Apr 15, 2019	SELL	$28.07 - $38.18 $7,859 - $10,690	-280 Reduced 4.7%	5,683 $677,000
Q4 2018 Jan 28, 2019	SELL	$26.99 - $37.37 $2,537 - $3,512	-94 Reduced 1.55%	5,963 $714,000
Q2 2018 Jul 31, 2018	BUY	$17.54 - $25.22 $16,926 - $24,337	965 Added 18.95%	6,057 $575,000
Q1 2018 Apr 20, 2018	SELL	$13.06 - $18.54 $5,981 - $8,491	-458 Reduced 8.25%	5,092 $378,000
Q4 2017 Jan 18, 2018	BUY	$11.12 - $15.38 $19,782 - $27,361	1,779 Added 47.18%	5,550 $318,000
Q3 2017 Oct 25, 2017	BUY	$11.36 - $18.98 $42,838 - $71,573	3,771	3,771 $184,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $28.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on First Bank & Trust with notifications on news.

Account